ABBVIE

Serial Number 98362225
Registration 7552423
700

Registration Progress

Application Filed
Jan 17, 2024
Under Examination
Approved for Publication
Aug 13, 2024
Published for Opposition
Aug 13, 2024
Registered
Oct 29, 2024

Trademark Image

ABBVIE

Basic Information

Serial Number
98362225
Registration Number
7552423
Filing Date
January 17, 2024
Registration Date
October 29, 2024
Published for Opposition
August 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 29, 2024
Registration
Registered
Classes
005

Rights Holder

AbbVie Inc.

03
Address
1 North Waukegan Road
Dept. V377, Bldg. AP34-2
North Chicago, IL 60064

Ownership History

AbbVie Inc.

Original Applicant
03
North Chicago, IL

AbbVie Inc.

Owner at Publication
03
North Chicago, IL

AbbVie Inc.

Original Registrant
03
North Chicago, IL

Legal Representation

Attorney
Cheryl A. Withycombe

USPTO Deadlines

Next Deadline
1917 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-29)
Due Date
October 29, 2030
Grace Period Ends
April 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Oct 29, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 29, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 13, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 9, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: Jan 1, 2013
First Use in Commerce: Jan 1, 2013

Classification

International Classes
005